Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 361-370 of 404 for multiple

Edit search filters
  1. A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

    Rochester, MN

  2. A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  3. Clinical Trial Enzyme Application Targeting Venous Leg Ulcers

    Jacksonville, FL

  4. A Study to Assess LXH254 in Patients with Previously Treated Unresectable or Metastatic BRAFV600 or NRAS Mutant Melanoma

    Rochester, MN

  5. Evaluation of a Clinical Tool to Assess Patient Treatment Experience and Self-Management (PETS-Now)

    Rochester, MN

  6. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies

    Rochester, MN

  7. A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of NIO752 in Participants with Progressive Supranuclear Palsy

    Rochester, MN

  8. The Validation of the CAP-PRI (Chronic Acquired Polyneuropathy-Patient Reported Index) in Patients with Acquired and Idiopathic Polyneuropathy

    Rochester, MN

  9. A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease

    Scottsdale/Phoenix, AZ

  10. A Study of Intravitreal REGN2176-3 in Patients with Neovascular ("Wet") Age-Related Macular Degeneration

    Jacksonville, FL

.

Mayo Clinic Footer